The pharmaceutical landscape is experiencing a shift with the emergence of GLP-1 transdermal systems . These innovative formulations offer a promising alternative to administering glucagon-like peptide-1 https://tiannanwvz216477.daneblogger.com/39657622/glp-1-patches-a-new-way-to-treat-blood-sugar